Dr. Rudy Tanzi, Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard University, Vice Chair of Neurology, Massachusetts General Hospital, and Chair of the Research Leadership Group for Cure Alzheimer’s Fund, has been elected to the prestigious National Academy of Medicine (NAM). The announcement from the academy recognized Rudy as, “…a pioneer and world leader in the areas of Alzheimer’s disease (AD), neurogenetics, and translating pathogenetic mechanisms underlying neurodegenerative diseases into novel therapeutics. He discovered numerous AD genes including the first three and developed the first complete human brain organoid model of AD, greatly accelerating drug discovery.”
NAM details the designation and involvement as follows: “New members are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. A diversity of talent among NAM’s membership is assured by its Articles of Organization, which stipulate that at least one-quarter of the membership is selected from fields outside the health professions — for example, from such fields as law, engineering, social sciences, and the humanities. The newly elected members bring NAM’s total membership to more than 2,400, which includes 198 international members.”
NAM continues, “Established originally as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors. NAM works alongside the National Academy of Sciences and National Academy of Engineering to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies of Sciences, Engineering, and Medicine also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding of STEMM. With their election, NAM members make a commitment to volunteer their service in National Academies activities.”
We are proud of Rudy for receiving this well-deserved distinction and grateful for his contributions to Alzheimer’s disease research and CureAlz.
